Effect of Ketone Ester Supplementation on Sleep and Recovery in Hypoxia
1 other identifier
interventional
13
1 country
1
Brief Summary
This study specifically aims to elucidate the effects of IEK on sleep and recuperation in hypoxia, after training in normoxia. These conditions are in line with the widely applied live-high train-low strategy. Moreover, blood and tissue oxygenation status, as well as cerebral blood flow and cognitive function will be assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2023
CompletedFirst Submitted
Initial submission to the registry
August 29, 2023
CompletedFirst Posted
Study publicly available on registry
September 29, 2023
CompletedSeptember 29, 2023
September 1, 2023
1 month
August 29, 2023
September 27, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Duration of different sleep stages
Measured using polysomnography
Throughout the entire duration of the night, up to 9 hours after individual bedtime
Exercise performance
Measured as the average power output (W) during a 30 minutes time trial
30 minutes on the second morning of the protocol
Change in nocturnal oxygen saturation
Measured using pulse oximetry
Throughout the entire duration of the night, up to 9 hours after individual bedtime
Absolute amount of nocturnal urinary catecholamine excretion
Measured using ELISA of collected nocturnal urine
Subjects empty bladder before sleep and urine will be collected throughout the entire duration of the night, up to 9 hours after individual bedtime and in the morning immediately after waking up
Study Arms (3)
Normoxia - placebo
PLACEBO COMPARATORBoth training and sleep in normoxia, supplemented with placebo
Hypoxia - placebo
EXPERIMENTALTraining in normoxia and sleep in hypoxia, supplemented with placebo
Hypoxia - ketones
EXPERIMENTALTraining in normoxia and sleep in hypoxia, supplemented with ketones
Interventions
Water, 5% collagen(w/w), octoacetate (1 mM)
A total of 75g ketone ester supplementation will be administered in 3 bouts of 25g in order to establish intermittent exogenous ketosis: twice immediately after training, and one 30 minutes before sleep. The ketone ester used is (R)-3-hydroxybutyl (R)-3-hydroxybutyrate
Eligibility Criteria
You may qualify if:
- Written informed consent must be obtained prior to any experimental procedures
- Males between 18 and 35 years old
- Recreational or competitive cyclists performing regular cycling training sessions with an average training volume of more than 6 hours per week
- Good health status confirmed by a medical screening
- Body Mass Index (BMI) between 18 and 25
- Normal sleep pattern as assessed by the Pittsburgh Sleep Quality Index
- Moderate sleep chronotype (extreme morning and evening chronotypes will be excluded), assessed by the Horne and Östberg questionnaire
You may not qualify if:
- Any kind of injury/pathology that is a contra-indication for hypoxic exposure and/or to perform high-intensity exercise, evaluated by a sport medical screening
- Intake of any medication or nutritional supplement that is known to affect exercise, performance or sleep. Intake will be assessed during recruitment and the sport medical screening.
- Intake of analgesics, anti-inflammatory agents, or supplementary anti-oxidants, from 2 weeks prior to the start of the study.
- Recent residence or training under hypoxia; more than 7 days exposure to altitude \> 1500m during the last 3 months preceding the study.
- Night-shifts or travel across time zones in the month preceding the study
- Blood donation within 3 months prior to the start of the study
- Smoking
- More than 3 alcoholic beverages per day
- Pre-existing, diagnosed psychiatric conditions or diagnosed anxiety
- Excessive daytime sleepiness as assessed by the Epworth scale
- Depression or anxiety as assessed by the Beck Depression Inventory and Beck Anxiety Inventory. Only a score in the range of 'normal ups and downs' (score 1-10) for depression or 'minimal anxiety' (score 0-7) for anxiety are tolerated.
- History of addiction or excessive caffeine/alcohol consumption assessed by a questionnaire
- Any other argument to believe that the subject is unlikely to successfully complete the full study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
KU Leuven
Leuven, Vlaams-Brabant, 3000, Belgium
Related Publications (1)
Stalmans M, Tominec D, Robberechts R, Lauriks W, Ramaekers M, Debevec T, Poffe C. A Single Night in Hypoxia Either with or without Ketone Ester Ingestion Reduces Sleep Quality without Impacting Next-Day Exercise Performance. Med Sci Sports Exerc. 2025 Apr 1;57(4):807-819. doi: 10.1249/MSS.0000000000003604. Epub 2024 Nov 18.
PMID: 39809236DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chiel Poffé, Dr.
KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 29, 2023
First Posted
September 29, 2023
Study Start
February 20, 2023
Primary Completion
March 31, 2023
Study Completion
March 31, 2023
Last Updated
September 29, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share